![]() |
|
Ferscha: FX is the only major asset class where Eurex has not historically been represented |
Frankfurt-based derivatives exchange Eurex last month unveiled plans to offer foreign exchange futures, a move that might come as a shock to US rival the Chicago Mercantile Exchange (CME), which has historically dominated the FX futures market. “FX is one of the fastest-growing markets in the world, and it is the only major financial asset class where Eurex has not historically been represented,” says Eurex CEO Rudolf Ferscha.
In 2004, daily FX volumes reached $1.9 trillion according to the Bank for International Settlements, with the fastest growth in OTC derivatives products such as forwards, swaps and options. The turnover of exchange-traded derivatives increased by a similar magnitude but exchange-traded currency derivatives still only constitute 1% of overall trading. Although futures make up the vast majority of this, the issue will be whether there’s sufficient scope for growth in exchange-traded futures.
“From Eurex’s point of view, I can see the logic behind this move but there’s no evidence that there will be an explosion in exchange-traded FX futures,” says David Poole, COO at research and advisory firm ClientKnowledge. “There’s a huge OTC market right now and many people have got used to the way this works. Trading futures contracts on an exchange will take away some of the benefits of calling up your bank and placing a trade.”
Eurex is already trying to entice the market with a generous multi-year incentive programme that will reward participants that consistently provide liquidity and proprietary order flow. Another lure will be its contract sizes. At present, the CME offers contracts whose standard size is $125,000 but Eurex hopes to turn investors’ heads by offering contracts as big as $250,000. This will be a big selling point to hedge funds, providing them with greater profit potential at a lower cost.
Ultimately the success of either exchange will depend on cost and liquidity. Eurex contracts are understood to be priced at 50 cents per side, compared with the CME’s $1.60, and will initially be listed on six major US dollar currency pairs, including the euro, Australian dollar, pound sterling, yen, Swiss franc and Canadian dollar. They will be traded on Eurex US from September, with a waiver on all trading fees for FX contracts for the rest of 2005.
However, the CME has good reason not to be too perturbed by this move. It set several FX volumes records last month, including a new total FX volume record of 748,050 contracts on June 8, 2005, representing $87 billion in notional value, and surpassing the previous record of 679,700 at the end of 2004. Approximately $40 billion-worth of FX futures contracts trade each day on CME.
It also recently announced plans to introduce a new one-year incentive programme in August, designed to attract large hedge funds and commodity trading advisers (CTAs) to its FX markets. Clients with more than $2 billion in assets under management will be eligible to trade CME FX products on the CME Globlex e-trading platform for 60 cents per side, compared with the current fee of $1.60.
“CME has a significant chunk of the market and good liquidity,” says a senior FX banker. “It will be interesting to see if Eurex can win enough liquidity to make it a serious threat.” Eurex says its contracts will be supported by a selected network of banks and market making firms, ensuring liquidity from launch.
Another FX specialist says: “This isn’t the first time that Eurex has taken an aggressive stance against its competitors. In 2003, it launched a US futures exchange, offering US treasury bond futures in competition with the Chicago Board of Trade, but it failed to fracture CBOT’s market share. “
Whether this latest initiative meets the same fate remains to be seen. Eurex is bullish that the recent increase in the popularity of FX as an asset class makes this a timely move. The FX futures market isn’t as developed as the treasury futures market, which stands Eurex in good stead to make a stab at becoming a credible competitor. “It’s not going to be a question of who will win this battle,” adds ClientKnowledge’s Poole. “Competition is needed in all markets and the success of this model will depend on the market growing rather than Eurex stealing existing market share from the CME.”
